BiotechTube
Home/Neuronascent/Kenneth Narducy, Ph.D., MBA
KN

Kenneth Narducy, Ph.D., MBA

Acting COO, Director

Neuronascent

Therapeutic Areas

Alzheimer's DiseaseParkinson's DiseaseDevelopmental DelayVeterinary Neurology

Neuronascent Pipeline

DrugIndicationPhase
NNI-362 (NNI-351)Alzheimer's DiseasePhase 2

Leadership Team at Neuronascent

JK
Judith Kelleher-Andersson, Ph.D.
Founder, President, CEO, Director
View full Neuronascent profile